Treatment of stage III neuroblastoma with emphasis on intensive induction chemotherapy: A report from the neuroblastoma group of the spanish society of pediatric oncology-Reference-Cited by-同舟云学术

Treatment of stage III neuroblastoma with emphasis on intensive induction chemotherapy: A report from the neuroblastoma group of the spanish society of pediatric oncology

Published:1995-01 Issue:1 Volume:24 Page:29-35
ISSN:0098-1532
Container-title:Medical and Pediatric Oncology
language:en
Short-container-title:Med. Pediatr. Oncol.

Author:

Castel V.,Badal M. D.,Bezanilla J. L.,Llombart A.,Ruiz-Jiménez J. I.,De Toledo J. Sánchez,Melero C.,Mulet J.

Publisher

Wiley

Subject

Cancer Research,Oncology,Pediatrics, Perinatology, and Child Health

Reference24 articles.

1. A proposed staging for children with neuroblastoma.Children's cancer study group A

2. Surgicopathologic staging of neuroblastoma: Prognostic significance of regional lymph node metastases

3. A population-based study of neuroblastoma incidence, survival, and mortality in North America.

4. Prognostic factors in neuroblastomas treated in denmark from 1943 to 1980:A statistical estimate of prognosis based on 253 cases

5. : “TNM Classification of Pediatric Tumors.” Geneva: UICC, 1982.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platinum-induced hearing loss after treatment for childhood cancer;Cochrane Database of Systematic Reviews;2016-08-03

2. Genetic analysis results of patients with a retinoblastoma refractory to systemic chemotherapy;Archivos de la Sociedad Española de Oftalmología (English Edition);2015-09

3. Resultados del analisis genético de los pacientes con retinoblastoma resistente a quimioterapia sistémica;Archivos de la Sociedad Española de Oftalmología;2015-09

4. Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: Results of the SIOPEN study;European Journal of Cancer;2013-11

5. Neuroblastoma: The impact of biology and cooperation leading to personalized treatments;Critical Reviews in Clinical Laboratory Sciences;2012-05-31